A case-control teratological study of spiramycin, roxithromycin, oleandomycin and josamycin.
Czeizel
A E
AE
Foundation for the Community Control of Hereditary Diseases-Department of Human Genetics and Teratology, National Center for Epidemiology, Budapest, Hungary.
Rockenbauer
M
M
Olsen
J
J
Sørensen
H T
HT
D000015:Abnormalities, Multiple / Q000139:chemically induced* / Q000453:epidemiology*; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D007231:Infant, Newborn; D015570:Josamycin / Q000009:adverse effects; D009827:Oleandomycin / Q000009:adverse effects; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D015575:Roxithromycin / Q000009:adverse effects; D015572:Spiramycin / Q000009:adverse effects; D011795:Surveys and Questionnaires
D000900:Anti-Bacterial Agents; D015575:Roxithromycin; D015572:Spiramycin; D015570:Josamycin; D009827:Oleandomycin